Biolidics Trims Loss in Q3 as Revenue Rises 7%
Biolidics: Financial Statements and Related Announcement-Third Quarter Results
Singapore Shares Surge as Inflation Eases Up; Biolidics Zooms 13%
Biolidics Completes Acquisition to Expand E-Sports Presence
Biolidics Ltd. Approves Key Share Issuance and Transfer
Biolidics Receives SGX Approval to List 946 Million Share
Biolidics Amends Share Subscription Agreement With Chairman
Biolidics Ltd Amends Subscription Agreement Terms
Biolidics: Financial Statements and Related Announcement-Half Yearly Results
Insiders' S$2.18m Investments In Red Following Biolidics' S$775k Dip In Market Value
Biolidics Enters Supplemental Agreement Tied to Shenzhen Network Technology Acquisition; Biolidics Shares Plummet 10%
Biolidics Incorporates Two Subsidiaries
Biolidics to Buy Shenzhen Xiaozhao Network; Secures SG$1.5 Million Loan
Biolidics Ltd Announces Major Acquisition and Funding
Biolidics Names Ex-Weiye Executive as Financial Controller
Biolidics' CEO Steps Down; Shares Surge 10%
Biolidics Places Subsidiary Under Voluntary Liquidation
Biolidics First Quarter 2024 Earnings: S$0.001 Loss per Share (Vs S$0.001 Loss in 1Q 2023)
Bioldics' Financial Controller Steps Down
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1
No Data
No Data